Year: 2024

International trial introduces another curative option for sickle cell disease 

The therapy, haploidentical bone marrow transplant with thiotepa and posttransplant cyclophosphamide, is as safe and more affordable than the recently FDA-approved myeloablative gene therapy and gene editing treatments.

Connie Orr honored as a Care Partner of the Year 

Orr is one of five care partners from across Vanderbilt Health recognized for their exceptional interaction, dedication and positive impact with patients, families and staff.

David Wasserman, groundbreaking researcher into exercise, insulin stimulation and metabolism, dies at 66

A fellow of the American Association for the Advancement of Science, his work has important implications for the treatment of diabetes and heart disease.

Gene variant may underlie diabetes disparities: study

The study was the largest ancestry-stratified, genetic estimation of the heritability of diabetic retinopathy conducted to date and included an unprecedented number of individuals of non-Hispanic African ancestry — more than 46,000.

Automated algorithm predicts risk of blood clots in hospitalized patients

This new entry to the field works in the background to provide real-time risk assessments, with no manual inputs from health care providers required.

VUMC Pets of the Day: Bane and Pinch

1 45 46 47 48 49 98